Epigenetic modulation through BET bromodomain inhibitors as a novel therapeutic strategy for progranulin-deficient frontotemporal dementia.
Rosenthal ZC, Fass DM, Payne NC, She A, Patnaik D, Hennig KM, Tesla R, Werthmann GC, Guhl C, Reis SA, Wang X, Chen Y, Placzek M, Williams NS, Hooker J, Herz J, Mazitschek R, Haggarty SJ.
Rosenthal ZC, et al. Among authors: guhl c.
Sci Rep. 2024 Apr 20;14(1):9064. doi: 10.1038/s41598-024-59110-7.
Sci Rep. 2024.
PMID: 38643236
Free PMC article.